References
- Ahrens R C, Harris J B, Milavetz G, Annis L, Ries R. Use of bronchial provocation with histamine to compare the pharmacodynamics of inhaled albuterol and metaproterenol in patients with asthma. J Allergy Clin Immunol 1987; 79: 876–882
- FDA guidance for in vivo bioequivalence studies of metaproterenol sulfate and albuterol inhalation aerosols (metered dose inhalers). 1989, issued February 9
- Bellamy D, Penketh A. A cumulative dose comparison between salbutamol and fenoterol metered dose aerosols in asthmatic patients. Postgrad Med J 1987; 63: 459–461
- Corris P A, Neville E, Nariman S, Gibson G J. Dose-response study of inhaled salbutamol powder in chronic airflow obstruction. Thorax 1983; 38: 292–296
- Lipworth B J, Clark R A, Dhillon D P, Brown R A, McDevitt D G. B-adrenoceptor responses to high doses of salbutamol in patients with bronchial asthma. Br J Clin Pharmacol 1988; 26: 27–30
- Nelson H S, Spector S L, Whitsett T L, George R B, Dwek J H. The bronchodilator response to inhalation of increasing doses of aerosolized albuterol. J Allergy Clin Immunol 1983; 72: 371–375
- Orgel H A, Meltzer E O, Welch M J, Kemp J P. Inhaled albuterol powder for the treatment of asthma. J Allergy Clin Immunol 1985; 75: 468–471
- Spector S L, Gomez M G. Dose-response effects of albuterol aerosol compared with isoproterenol and placebo aerosols. J Allergy Clin Immunol 1977; 59: 280–286
- Svedmyr N, Lofdahl C G, Svedmyr K. The effect of powder aerosol compared to pressurized aerosol. Eur J Respir Dis 1982; 63(Suppl 119)81–88
- Vanethen A S, Britton J R, Ebden P, Cookson J B, Wharrad H J, Tattersfield A E. High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Resp Dis 1988; 138: 850–855
- Morris J, Milledge J S, Moszoro H, Higgins A. The efficacy of drug delivery by a pear-shaped spacer and metered dose inhaler. Br J Dis Chest 1984; 78: 383–387
- Littner M R, Tashin D P, Calvarese B, Bautiska M. Acute bronchial and cardiovascular effects of increasing doses of pirbuterol acetate aerosol in asthma. Ann Allergy 1982; 48: 14–20
- Pennock B E, Rogers R M, Ryan B R, Ayrs L N. Aerosol administration of fenoterol hydrobromide (Th 1165a) in subjects with reversible obstructive airway disease. Chest 1977; 72: 731–736
- Duncan D, Paterson I C, Cromptom G K. Comparison of the bronchodilator effects of salbutamol inhaled as a dry powder and by conventional pressurized inhaler. Br J Clin Pharmacol 1977; 4: 669–671
- Madsen E B, Bundgaard A, Hidinger K G. Cumulative dose-response study comparing terbutaline pressurized aerosol administered via a pearshaped spacer and terbutaline in a nebulized solution. Eur J Clin Pharmacol 1982; 23: 27–30
- Stewart D E, Gillies A DJ. A dose response study comparing Duovent vs salbutamol. NZ Med J 1987; 100: 742–744
- Larsson S, Svedmyr N. Bronchodilating effect and side effects of beta2-adrenoceptor stimulants by different modes of administration (tablets, metered aerosol and combinations thereof). Am Rev Respir Dis 1977; 116: 861–869
- Bartoni A, Grieco A, Vibelli C. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. Eur J Respir Dis 1980; 61: 143–150
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244
- Crapo R O, Morris A H, Gardner R M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659–664